DarDoc Research

GLP-1 Trial & Approval Tracker

Compare GLP-1 trial arms

Compare results within a trial or inspect the context behind results from different studies.

OASIS 4

Wegovy tablets

Without diabetes · 64 weeks · n=307

Double-blind, placebo-controlled. Treatment-policy analysis.

Mean body weight change at 64 weeks
  • Oral semaglutide 25 mg−13.6%
  • Placebo−2.2%

A direct comparison uses arms from the same trial. Switch to Two studies to inspect the context behind separate results.